Lupin bags USFDA nod for Ipratropium Bromide Nasal Solution for rhinorrhea Written By Ruchika Sharma11 Feb 2025 10:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (USFDA) for...
Natco Pharma gets final approval for Bosentan tablets for oral suspension Written By Ruchika Sharma10 Feb 2025 11:30 AM ISTHyderabad: NATCO Pharma Limited has announced final approval of its Abbreviated New Drug Application (ANDA) for Bosentan tablets for oral...
Sun Pharma to pay Rs 160.2 crore penalty, tops list of 6 drug majors facing tax scrutiny Farhat Nasim7 Feb 2025 7:31 PM ISTNew Delhi: Six leading pharmaceutical companies, Sun Pharmaceutical Industries, Ipca Laboratories, Indoco Remedies, Aurobindo Pharma, Lupin Limited,...
Lupin bags tentative USFDA okay for generic HIV Medication Written By Ruchika Sharma4 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug...
USFDA completes inspection of Lupin Somerset facility with no observations Ruchika Sharma3 Feb 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a Pre-Approval...
Lupin's Generic Entresto Approved by USFDA, Set to Rival Novartis' Bestseller Farhat Nasim29 Jan 2025 8:04 PM ISTMumbai: In a fresh challenge to Novartis' blockbuster heart failure drug Entresto, Indian generics maker Lupin has received approval from the U.S....
USFDA nod to Lupin Ipratropium Bromide Nasal Solution for runny nose Written By Ruchika Sharma29 Jan 2025 3:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration (U.S....
Lupin, Avas unveil myotonia treatment NaMuscla in Italy Written By Ruchika Sharma29 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited and Avas Pharmaceuticals SRL have announced the launch of Lupin's orphan drug NaMuscla (mexiletine) in...
Lupin receives USFDA approval for heart failure drug Written By Ruchika Sharma24 Jan 2025 4:24 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug Administration...
Lupin gets USFDA tentative nod for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension for HIV-1 infection Written By Ruchika Sharma24 Jan 2025 12:30 PM ISTMumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration...
Lupin unveils pregnancy prevention drug Minzoya in US Ruchika Sharma14 Jan 2025 11:30 AM ISTMumbai: Global pharma major Lupin Limited has announced the launch of Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous...
Lupin Cystic fibrosis drug gets tentative approval from USFDA Written By Ruchika Sharma10 Jan 2025 2:30 PM ISTIvacaftor Oral Granules, 25 mg, 50 mg and 75 mg per unit dose packet are indicated for cystic fibrosis treatment in patients aged 4 months and older.
